PT Etana Biotechnologies Indonesia

PT Etana Biotechnologies Indonesia (Etana) is an Indonesian biopharmaceutical company focused on the research, development, and production of innovative and affordable biological therapies. Established in 2014, it addresses a range of metabolic, autoimmune, and life-threatening diseases, including cancer. Through strategic global partnerships and advanced local manufacturing capabilities, Etana expands access to high-quality treatments while supporting the growth of Indonesia’s healthcare and pharmaceutical ecosystem.

Scroll to Top